Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03433378 · ClinicalTrials.gov registry record · Early Phase 1
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris
A Early Phase 1 study, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 700
- Enrollment target
NCT03433378 is a Early Phase 1 study that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 700 participants.
The verdict
NCT03433378, a Early Phase 1 study, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 700 participants
- Enrollment target
Study Summary
Bioequivalence study comparing Tretinoin Cream, 0.05% to RETIN-A®.
Interventions
- DRUG Vehicle of the test product
- DRUG Tretinoin cream, 0.05%
- DRUG RETIN-A® (tretinoin) cream, 0.05%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2018-01-26 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03433378
The ClinicalTrials.gov registry entry for NCT03433378 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharmaceutical Industries, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vehicle of the test product is the first listed.
NCT03433378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03433378 about?
NCT03433378 is a clinical study titled "To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris". Bioequivalence study comparing Tretinoin Cream, 0.05% to RETIN-A®.
What is the current status of trial NCT03433378?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 700 participants. The study started on 2017-08-04. Estimated completion is 2018-01-26.
What interventions are being tested in trial NCT03433378?
The interventions under investigation include: Vehicle of the test product (DRUG), Tretinoin cream, 0.05% (DRUG), RETIN-A® (tretinoin) cream, 0.05% (DRUG).
Who is sponsoring clinical trial NCT03433378?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.